Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$260.5K
Current Assets
2022 Q3
Current Liabilities
2022 Q3
$2.846M
Current Ratio
2022 Q3
0.19%
Total Assets
2022 Q3
Total Liabilities
2022 Q3
Book Value
2022 Q3
-$2.841M
Cash
2022 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $118.04 Thousand

About QUANTRX BIOMEDICAL CORP

QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. The company is headquartered in Tualatin, Oregon. The firm is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents (the Diagnostics Business). The firm's platforms include inSync, Unique and original equipment manufacturer (OEM) branded over-the-counter and laboratory testing products based on its core intellectual property related to the Company PAD technology. Its OTC Business includes commercialization of its InSync feminine hygienic interlabial pad, the Unique Miniform for hemorrhoid application, and other treated miniforms, as well as maintaining established and continuing licensing relationships related to the OTC Business. The company also owns certain diagnostic testing technology that is based on its lateral flow patents.

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AMERICAN BIO MEDICA CORP THC Therapeutics, Inc. Escalon Medical Corp Zosano Pharma Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support